humanized anti-IL-12 antibodies (NIAID)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namehumanized anti-IL-12 antibodies (NIAID)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-12 receptor inhibitors
TargetsInterleukin-12 receptor
Therapy Area/IndicationsColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsColitis

Other Information

ATC CodeN/A
Related LinksN/A